Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:alternativeName |
OFP-857
OFP857 |
| gptkbp:canBe |
antiviral drug
treatment of COVID-19 |
| gptkbp:chemicalClass |
small molecule
|
| gptkbp:clinicalTrialPhase |
Phase 2
|
| gptkbp:developer |
OncoFusion Therapeutics
|
| https://www.w3.org/2000/01/rdf-schema#label |
OFP 857
|
| gptkbp:mechanismOfAction |
inhibits SARS-CoV-2 replication
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:bfsParent |
gptkb:Volkswagen_Beetle_#53
|
| gptkbp:bfsLayer |
6
|